Should I buy or sell Fisher & Paykel Healthcare stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FSPKF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FSPKF, but not buy additional shares or sell existing shares. View FSPKF analyst ratings or view top-rated stocks .

How have FSPKF shares performed in 2023?

Fisher & Paykel Healthcare's stock was trading at $13.63 at the beginning of 2023. Since then, FSPKF stock has increased by 3.5% and is now trading at $14.11. View the best growth stocks for 2023 here .

Are investors shorting Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,307,900 shares, an increase of 15.6% from the October 31st total of 1,131,300 shares. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is currently 654.0 days. View Fisher & Paykel Healthcare's Short Interest .

Is Fisher & Paykel Healthcare a good dividend stock?

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) pays an annual dividend of $0.07 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Fisher & Paykel Healthcare?

Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Fisher & Paykel Healthcare Stock Price, News & Analysis (OTCMKTS:FSPKF)

$14.11

0.00 (0.00%)

(As of 12/5/2023 ET)

Compare

Today's Range: $14.11
▼
$14.11
50-Day Range: $12.00
▼
$14.11
52-Week Range: $12.00
▼
$16.69

Volume: N/A
Average Volume: 700 shs
Market Capitalization: N/A

P/E Ratio: 83.18
Dividend Yield: 0.46%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

About Fisher & Paykel Healthcare Stock (OTCMKTS:FSPKF)

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

FSPKF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FSPKF Stock News Headlines

November 28, 2023 | msn.com

Fisher & Paykel ups pre-Christmas dividend

November 28, 2023 | marketwatch.com

Fisher & Paykel Lifts 1H Profit 12% Amid Easing Freight Costs

December 6, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

October 14, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) institutional investors lost 5.6% last week but have benefitted from longer-term gains

October 8, 2023 | markets.businessinsider.com

Jarden Remains a Hold on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

September 26, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Polynovo Limited (OtherCALZF)

September 3, 2023 | msn.com

Fisher & Paykel’s 30-year master plan requires ‘discipline’

August 28, 2023 | msn.com

Fisher and Paykel Healthcare forecasting return to revenue growth

December 6, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

August 14, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare (NZSE:FPH) Is Reinvesting At Lower Rates Of Return

May 31, 2023 | markets.businessinsider.com

Jarden downgrades Fisher & Paykel Healthcare Corporation Limited (FSPKF) to a Hold

May 25, 2023 | markets.businessinsider.com

Citi Remains a Hold on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

May 24, 2023 | markets.businessinsider.com

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Gets a Buy from Jarden

May 12, 2023 | marketwatch.com

Obstructive Sleep Apnea Devices Market Size 2023 Analysis by Global Key Players -ResMed, Philips, Fisher & Paykel Healthcare

May 9, 2023 | marketwatch.com

Sleep Apnea Monitoring Instruments Market 2023 Is Growing Worldwide – ResMed, Philips Healthcare Fisher & Paykel Healthcare

May 9, 2023 | marketwatch.com

Obstructive Sleep Apnea Devices Market Size & Share Analysis – Latest Insight Report | ResMed, Philips, Fisher & Paykel Healthcare

May 5, 2023 | marketwatch.com

CPAP Devices Market Overview 2023 to 2029, Future Trends and Industry Forecast | ResMed, Philips Respironics, Fisher & Paykel Healthcare

March 6, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

February 6, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare (NZSE:FPH) jumps 4.7% this week, though earnings growth is still tracking behind five-year shareholder returns

January 15, 2023 | finance.yahoo.com

Is Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Recent Stock Performance Tethered To Its Strong Fundamentals?

December 1, 2022 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and IVERIC bio (ISEE)

November 30, 2022 | finance.yahoo.com

Fisher & Paykel Healthcare First Half 2023 Earnings: Beats Expectations

November 28, 2022 | seekingalpha.com

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2023 Earnings Call Transcript

October 9, 2022 | finance.yahoo.com

A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

September 23, 2022 | finance.yahoo.com

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

September 3, 2022 | finance.yahoo.com

Lisa E. McIntyre Is The Independent Non-Executive Director of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) And They Just Picked Up 125% More Shares

September 1, 2022 | benzinga.com

Sleep Apnea Devices Market 2022-2027: Industry Overview, Share, Trends, Growth, COVID-19 Impact And Forecast Analysis

See More Headlines

Receive FSPKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:FSPKF
CUSIP: N/A
CIK: N/A
Web: www.fphcare.com
Phone: (649) 574-0100
Fax: N/A
Employees: 6,391
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 83.18
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Lewis G. Gradon (Age 62)
MD, CEO & Executive Director
Comp: $1.51M
Ms. Lyndal York
Chief Financial Officer
Dr. Andrew Somervell
Vice President of Products & Technology
Hayden Brown
Head of Capital Markets & Investor Relations
Raelene Leonard
Company Secretary & General Counsel
Daniel Adolph
Senior Communications & Investor Relations Manager
Mr. Paul N. Shearer B.Com.
Senior Vice President of Sales & Marketing
Ms. Nicola Talbot
Vice President of Human Resources
Mr. Jonathan Rhodes
Vice President of Supply Chain, Facilities & Sustainability
Mr. Marcus Driller
Vice President of Corporate

Key Competitors

View All Competitors

FSPKF Stock Analysis - Frequently Asked Questions

Should I buy or sell Fisher & Paykel Healthcare stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FSPKF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FSPKF, but not buy additional shares or sell existing shares.
View FSPKF analyst ratings or view top-rated stocks.
How have FSPKF shares performed in 2023?: Fisher & Paykel Healthcare's stock was trading at $13.63 at the beginning of 2023. Since then, FSPKF stock has increased by 3.5% and is now trading at $14.11.
View the best growth stocks for 2023 here.
Are investors shorting Fisher & Paykel Healthcare?: Fisher & Paykel Healthcare saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,307,900 shares, an increase of 15.6% from the October 31st total of 1,131,300 shares. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is currently 654.0 days.
View Fisher & Paykel Healthcare's Short Interest.

Is Fisher & Paykel Healthcare a good dividend stock?: Fisher & Paykel Healthcare (OTCMKTS:FSPKF) pays an annual dividend of $0.07 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Fisher & Paykel Healthcare?: Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:FSPKF) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial